Meriem Koual

Dr. Meriem Koual


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in Environmental Health
Verified
Journal Article
Open access
PDF file
MKMeriem Koual
Meriem Koual
CTCéline Tomkiewicz
Céline Tomkiewicz
GCGerman Cano-Sancho
German Cano-Sancho
JAJean-Philippe Antignac
Jean-Philippe Antignac
ABAnne-Sophie Bats
Anne-Sophie Bats
XCXavier Coumoul
Xavier Coumoul
Breast cancer (BC) is one of the most common causes of cancer in the world and the second leading cause of cancer deaths among women. Mortality is associated mainly with the development of metastases. Identification of the mechanisms involved in metastasis formation is, therefore, a major public health issue. Among the proposed risk factors, chemical environment and pollution are increasingly suggested to have an effect on the signaling pathways involved in metastatic tumor cells emergence and progression. The purpose of this article is to summarize current knowledge about the role of environmental chemicals in breast cancer progression, metastasis formation and resistance to chemotherapy. Through a scoping review, we highlight the effects of a wide variety of environmental toxicants, including persistent organic pollutants and endocrine disruptors, on invasion mechanisms and metastatic processes in BC. We identified the epithelial-to-mesenchymal transition and cancer-stemness (the stem cell-like phenotype in tumors), two mechanisms suspected of playing key roles in the development of metastases and linked to chemoresistance, as potential targets of contaminants. We discuss then the recently described pro-migratory and pro-invasive Ah receptor signaling pathway and conclude that his role in BC progression is still controversial. In conclusion, although several pertinent pathways for the effects of xenobiotics have been identified, the mechanisms of actions for multiple other molecules remain to be established. The integral role of xenobiotics in the exposome in BC needs to be further explored through additional relevant epidemiological studies that can be extended to molecular mechanisms.

30 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
CDCarolina Duarte-Hospital
Carolina Duarte-Hospital
ATArnaud Tête
Arnaud Tête
FBFrançois Brial
François Brial
LBLouise Benoit
Louise Benoit
MKMeriem Koual
Meriem Koual
SBSylvie Bortoli
Sylvie Bortoli
Environmental factors including diet, sedentary lifestyle and exposure to pollutants largely influence human health throughout life. Cellular and molecular events triggered by an exposure to environmental pollutants are extremely variable and depend on the age, the chronicity and the doses of exposure. Only a fraction of all relevant mechanisms involved in the onset and progression of pathologies in response to toxicants has probably been identified. Mitochondria are central hubs of metabolic and cell signaling responsible for a large variety of biochemical processes, including oxidative stress, metabolite production, energy transduction, hormone synthesis, and apoptosis. Growing evidence highlights mitochondrial dysfunction as a major hallmark of environmental insults. Here, we present mitochondria as crucial organelles for healthy metabolic homeostasis and whose dysfunction induces critical adverse effects. Then, we review the multiple mechanisms of action of pollutants causing mitochondrial toxicity in link with chronic diseases. We propose the Aryl hydrocarbon Receptor (AhR) as a model of “exposome receptor”, whose activation by environmental pollutants leads to various toxic events through mitochondrial dysfunction. Finally, we provide some remarks related to mitotoxicity and risk assessment.

1 May 2021 in Gynecologic Oncology
Verified
Journal Article
Closed access
MKMeriem Koual
Meriem Koual
LBLouise Benoit
Louise Benoit
HNHuyen-Thu Nguyen-Xuan
Huyen-Thu Nguyen-Xuan
EBEnrica Bentivegna
Enrica Bentivegna
HAHenri Azaïs
Henri Azaïs
ABAnne-Sophie Bats
Anne-Sophie Bats

23 April 2021 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
RMRosa Montero-Macias
Rosa Montero-Macias
MKMeriem Koual
Meriem Koual
CCCéline Crespel
Céline Crespel
MFMarie Aude Le Frére-Belda
Marie Aude Le Frére-Belda
HHHélène Blons Hélène
Hélène Blons Hélène
ABAnne-Sophie Bats
Anne-Sophie Bats
Background: Homologous recombination deficiency is a marker of response to poly(ADP-ribose) polymerase inhibitors in different cancer types including ovary, prostate, and pancreatic cancer. To date, no report about poly(ADP-ribose) polymerase inhibitors has been published on cervical cancer. Case presentation: Here we present the case of a patient with cervical cancer treated in this setting. A 49-year-old woman diagnosed with International Federation of Obstetricians and Gynecologists stage 2018 IIIC2 locally advanced undifferentiated cervical cancer received first-line chemoradiotherapy followed by carboplatin, paclitaxel, and bevacizumab with partial response. Because of a family history of cancers, the patient was tested and found positive for a pathogenic BRCA1 germline and somatic mutation, which motivated bevacizumab plus olaparib maintenance treatment. A simple hysterectomy was performed after 2 years stable disease; pathological report showed complete pathological response, and 12 months follow-up showed no recurrence. Conclusion: Poly(ADP-ribose) polymerase inhibitors could be an alternative maintenance treatment for patients with persistent advanced cervical cancer previously treated with platinum, especially when familial history of cancers is reported. Clinical trials using poly(ADP-ribose) polymerase inhibitors for advanced cervical cancer are warranted.

11 December 2023 in Journal of Visceral Surgery
Verified
Journal Article
Closed access
AGAnouk Grobon
Anouk Grobon
FHFlorence Huang
Florence Huang
GSGlenn Simon-Rivé
Glenn Simon-Rivé
LBLouise Benoit
Louise Benoit
MKMeriem Koual
Meriem Koual

27 February 2023 in Toxicological Sciences
Verified
Journal Article
Closed access
PDF file
LBLouise Benoit
Louise Benoit
CTCeline Tomkiewicz
Celine Tomkiewicz
MDMaxime Delit
Maxime Delit
HKHanna Khider
Hanna Khider
KAKarine Audouze
Karine Audouze
MKMeriem Koual
Meriem Koual
Breast cancer is a major public health issue and the role of pollutants in promoting breast cancer progression has recently been suggested. We aimed to assess if a mixture of pollutants, cigarette smoke, could favor the aggressivity of breast cancer cells. We also evaluated the impact of the tumor microenvironment, largely represented by adipocytes, in mediating this modification of cell phenotype. Breast cancer cells lines, MCF-7 were cultured using a transwell coculture model with preadipocytes hMADS cells or were cultured alone. Cells were treated with cigarette smoke extract (CSE) and the four conditions: control, treated by CSE, coculture, and coexposure (coculture and CSE) were compared. We analyzed morphological changes, cell migration, resistance to anoikis, stemness, epithelial-to-mesenchymal transition (EMT), and the presence of hormonal receptors in each condition. A complete transcriptomic analysis was carried out to highlight certain pathways. We also assessed whether the aryl hydrocarbon receptor (AhR), a receptor involved in the metabolism of xenobiotics, could mediate these modifications. Several hallmarks of metastasis were specific to the coexposure condition (cell migration, resistance to anoikis, stemness characterized by CD24/CD44 ratios and ALDH1A1 and ALDH1A3 rates) whereas others (morphological changes, EMT, loss of hormonal receptors) could be seen in the coculture condition and were aggravated by CSE (coexposure). Moreover, MCF-7 cells presented a decrease in hormonal receptors, suggesting an endocrine treatment resistance. These results were confirmed by the transcriptomic analysis. We suggest that the AhR could mediate the loss of hormonal receptor and the increase in cell migration